Avalo Therapeutics (AVTX) Competitors

Tectonic Therapeutic (NASDAQ:TECX) and Avalo Therapeutics (NASDAQ:AVTX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability.

Does the media prefer TECX or AVTX?

In the previous week, Avalo Therapeutics had 21 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 26 mentions for Avalo Therapeutics and 5 mentions for Tectonic Therapeutic. Avalo Therapeutics' average media sentiment score of 0.66 beat Tectonic Therapeutic's score of 0.64 indicating that Avalo Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tectonic Therapeutic	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Avalo Therapeutics	3 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, TECX or AVTX?

Tectonic Therapeutic has a beta of 2.71, indicating that its share price is 171% more volatile than the S&P 500. Comparatively, Avalo Therapeutics has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in TECX or AVTX?

62.6% of Tectonic Therapeutic shares are held by institutional investors. Comparatively, 87.1% of Avalo Therapeutics shares are held by institutional investors. 9.2% of Tectonic Therapeutic shares are held by company insiders. Comparatively, 0.3% of Avalo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer TECX or AVTX?

Avalo Therapeutics received 3 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 48.00% of users gave Avalo Therapeutics an outperform vote.

Company	Underperform	Outperform
Tectonic Therapeutic	Outperform Votes 9 100.00%	Underperform Votes No Votes
Avalo Therapeutics	Outperform Votes 12 48.00%	Underperform Votes 13 52.00%

Which has higher valuation and earnings, TECX or AVTX?

Tectonic Therapeutic has higher earnings, but lower revenue than Avalo Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tectonic Therapeutic	N/A	N/A	$12.16M	-$6.53	-2.86
Avalo Therapeutics	$441K	204.73	-$31.54M	N/A	N/A

Is TECX or AVTX more profitable?

Tectonic Therapeutic's return on equity of -35.53% beat Avalo Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tectonic Therapeutic	N/A	-35.53%	-31.97%
Avalo Therapeutics	N/A	-442.16%	122.99%

Do analysts rate TECX or AVTX?

Tectonic Therapeutic presently has a consensus price target of $77.75, suggesting a potential upside of 316.89%. Avalo Therapeutics has a consensus price target of $33.00, suggesting a potential upside of 290.07%. Given Tectonic Therapeutic's stronger consensus rating and higher probable upside, analysts clearly believe Tectonic Therapeutic is more favorable than Avalo Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tectonic Therapeutic	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17
Avalo Therapeutics	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86

Summary

Tectonic Therapeutic beats Avalo Therapeutics on 8 of the 15 factors compared between the two stocks.